Robin K. Kelley

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Box 0981, UCSF

San Francisco, CA 94143-0981

United States

SCHOLARLY PAPERS

3

DOWNLOADS

303

TOTAL CITATIONS

8

Scholarly Papers (3)

1.

Nivolumab Versus Sorafenib Treatment in Advanced Hepatocellular Carcinoma (CheckMate 459): A Randomised, Multicentre, Open-Label, Phase 3 Trial

Number of pages: 47 Posted: 16 Aug 2021
The University of Hong Kong, National Cancer Center, Korea, University of California, Los Angeles (UCLA) - David Geffen School of Medicine, National Taiwan University - Department of Internal Medicine, Anger University Hospital - HepatoGastroenterology Department, Centre Eugène Marquis - Medical Oncology, Kindai University - Department of Gastroenterology and Hepatology, Memorial Sloan Kettering Cancer Center - Department of Medicine, Croix Rousse Hospital - Hepatology Unit, Sorbonne University - ssistance Publique Hôpitaux de Paris, M. Sklodowska-Curie Memorial National Cancer Research Institute, University Hospital Ulm - Helios Klinikum Emil von Behring GmbH, National Cancer Centre Singapore - Division of Medical Oncology, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, Medical University of Vienna - Department of Internal Medicine III, Hôpital Avicenne (APHP) - Centre Hospitalier Universitaire de Montpellier,, Medical University of Gdańsk - Department of Clinical Oncology and Radiotherapy, Kyorin University - Department of Medical Oncology, Memorial Sloan Kettering Cancer Center - Department of Medicine, University of Southern California - Norris Comprehensive Cancer Center, University of Navarra - Department of Cardiology and Cardiovascular Surgery, Bristol Myers Squibb, Bristol Myers Squibb, Bristol Myers Squibb, Bristol Myers Squibb, Bristol Myers Squibb and Carlos III National Institute of Health - Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd)
Downloads 215 (306,473)
Citation 6

Abstract:

Loading...

hepatocellular carcinoma, liver cancer, nivolumab, PD-1 inhibitor, sorafenib, immuno-oncology, CheckMate

2.

A Pan-Cancer Census of Dominant Tumor Immune Archetypes

Number of pages: 99 Posted: 23 Apr 2021
University of California, San Francisco (UCSF) - UCSF CoLabs, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - ImmunoX Initiative, University of California, San Francisco (UCSF) - UCSF CoLabs, University of California, San Francisco (UCSF) - UCSF CoLabs, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, Fred Hutchinson Cancer Research Center - Translational Research Program, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, Aix-Marseille University - Centre d'Immunologie de Marseille-Luminy, University of California, San Francisco (UCSF) - UCSF CoLabs, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, Independent, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - Division of Hematology and Oncology, University of California, San Francisco (UCSF) - Department of Medicine, University of California, San Francisco (UCSF) - Department of Otolaryngology, University of California, San Francisco (UCSF) - Department of Neurological Surgery, University of California, San Francisco (UCSF) - ImmunoX Initiative, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - UCSF CoLabs, University of California, San Francisco (UCSF) - UCSF CoLabs, Sorbonne University - Centre d'Immunologie et des Maladies Infectieuses, University of California, San Francisco (UCSF) - Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF) - Department of Microbiology and Immunology and University of California, San Francisco (UCSF) - Department of Pathology
Downloads 56 (803,941)
Citation 1

Abstract:

Loading...

3.

Circulating Monocytes Associated with Anti-PD-1 Resistance in Human Biliary Cancer Induce T Cell Paralysis

Number of pages: 51 Posted: 14 Dec 2021
University of California, San Francisco (UCSF), University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of Washington, University of Washington, University of California, San Francisco (UCSF) - Division of Rheumatology, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - UC Berkeley-UC San Francisco Graduate Program in Bioengineering and University of California, San Francisco (UCSF)
Downloads 32 (1,017,357)
Citation 1

Abstract:

Loading...

Immunotherapy, myeloid cells, monocytes, anti-PD-1, biliary tract cancer